GCGR and type 2 diabetes mellitus: Furthermore, GCGR knockdown abolished the glucagon-mediated deactivation of AMPK and activation of MAPK (Figure 6D), resulting in induction of an inhibitory effect of tumor growth in type 2 diabetes model mice.